News

TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has reached several important milestones in its initiative to realize efficiencies across clinical trial investigator and site qualification and training ("SQT") efforts.

Senior clinical executives from top pharmaceutical companies, including AstraZeneca and GlaxoSmithKline (GSK), alongside leading contract research organizations and representatives from the Association of Clinical Research Professionals (ACRP) and CenterWatch, met recently to set the quality standards and define the competencies for a global competition to recognize and encourage talented researchers in North and South America.

With ISR?s newest market research report (?Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing?) Mr. Schafer is back to draw comparisons and share data from their latest survey.

Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.

The Supreme Court decision blocking patents on naturally-occurring genes has generated predictions of doom for biotech innovation, along with expectations of more healthy competition in discovering new treatments and diagnostics.

Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.

Medidata Minute Episode 2: Recorded live at the Forbes Health Care Summit, Harlan Krumholz, Professor of Medicine Epidemiology & Public Health, Yale University and Andy Slavitt, group executive vice president at Optum discuss regulation in healthcare

Multimedia: Editorial Director Lisa Henderson talks with Steve Powell, PRA Executive VP Clinical Informatics and Late Phase Services about PRA's Informatics Expansion at its new Swansea, Wales office

Video Blog-- Strategic Outsourcing: A Concept for Debate? Are strategic partnerships in a too-early-to-tell stage? A passing fad or here to stay

Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials